Sepsis Market Development and Growth Opportunities by Forecast 2027

The Global Sepsis Diagnostics Market size was estimated to be USD 419.65 million in 2019 and is expected to surpass USD 841.58 million by the year 2027, growing at a CAGR of 9%.

According to the current analysis of Reports and Data, the global Sepsis Market was valued at USD 419.65 Million in 2019 and is expected to reach USD 841.58 million by the year 2027, at a CAGR of 9.0%. Sepsis is one of the significant challenges faced by hospitals. Sepsis is a medical condition caused by an overactive immune response to an infection. The immune system releases chemicals for protecting the body from disease; however, excess of these chemicals causes other severe conditions, including inflammation, blood clots, and leaky blood vessels. The unsteady blood flow causes a lack of proper blood flow to all the body organs leading to organ failure and in extreme conditions, septic shock. Sepsis is most common in infants, pregnant women, sick people, and the old population. Thus, a rise in geriatric population has led to an increase in the Sepsis activities. According to the World Health Organization, Sepsis is estimated to affect 30 million people worldwide every year, leading to the death of at least 6 million people. Growing initiatives taken by the government to increase the awareness related to Sepsissepsis is expected to drive the market growth for Sepsis Diagnostic further. Additionally, fewer infant deaths have resulted in more babies being born around the world. Additionally, this raises the possibility that infants will develop sepsissepsis. According to a report by the Sepsis Organization, 6,800 children die each year as a result of severe sepsis. Intensive research and increased investments in the development of the healthcare sector is expected to introduce effective treatments for Sepsissepsis and early diagnostic techniques. For instance, MARS-India, an observational study, was conducted to acquire new knowledge that will provide accurate information about the microorganisms and the causes for Sepsissepsis.

Request Free Sample Copy @

Further key findings from the report suggest

  • Sepsis market is growing at a CAGR of 9% in Asia Pacific followed by North America and Europe with 8.7 % and 8.8% CAGR respectively. High prevalence of chronic diseases is expected to drive the market growth.
  • As of 2019, Blood Culture technology segment dominated Sepsis which holds 37.3% of the global market. North America regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions.
  • The market of sepsis diagnostic is driven by the increase in sepsis cases, caused by gram-positive bacteria. The gram-positive bacterium has led to an increase in the number of patients with severe sepsis conditions and septic shock.
  • Introduction of new products for diagnostic purposes is expected to majorly drive the market for Sepsis in the coming years. For example, VIDAS B•R•A•H•M•S PCT, an automated assay measuring procalcitonin (PCT) levels launched by a leading in vitro diagnostic company, BioMérieux, enables the healthcare professions to take important decisions related to the recommendation of antibiotics for the patient.
  • The key players are adopting strategies like partnerships, mergers acquisitions, expansion and launch of new products. The partnership of Thermo Fisher Scientific and BioMérieux for improved detection of sepsis with the help of PCT Biomarker is expected to further drive the market for Sepsis.
  • Blood transfusion of infected is one of the leading causes for increase in sepsis cases. To prevent spread of sepsis through blood transfer, Becton, Dickinson and Company introduced a new product called BD BACTEC. This is a platelet quality control media, which enables the experts and healthcare professionals to effectively identify the infected platelet units.
  • Sepsis is a fatal bacterial infection that leads to blot clots and inflammation in the body slowly progressing towards multiple organ failure. Thus controlling the infection in its infant stage is very essential. To make this possible, European Union gave its approval for CytoSorb, a blood purification antibiotic that reduces the inflammation and saves the patient from the life-threatening infection.
  • The U.S. Centers for Disease Control and Prevention states that sepsis ranks 9th as the leading infection related deaths in the U.S. and also is the most expensive disease treatment in the United States.
  • Many researches have been conducted on Sepsis. Some focus on the symptoms, causes and prevention methods while the other focuses on the microbiological level. For instance, in 2016, The National Institutes of Health published a report on Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI).

Key Players covered in this report are

BioMérieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), and Abbott (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), CytoSorbents (US), and EKF (US).

Inquiry Before Buying @

Product Type (Revenue, USD Million; 2017–2027)

  • Blood Culture Media
  • Assays Reagents
  • Instruments
  • Software
  • Others

Technology Type (Revenue, USD Million; 2017–2027)

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

Pathogens Type (Revenue, USD Million; 2017–2027)

  • Bacterial Sepsis
    • Gram-Positive Bacteria
    • Gram-Negative Bacteria
  • Fungal Sepsis
  • Others

Method Type (Revenue, USD Million; 2017–2027)

  • Conventional Diagnostic
  • Automatic Diagnostic

Test Type (Revenue, USD Million; 2017–2027)

  • Laboratory Tests
  • Point-of-care Tests

End Use (Revenue, USD Million; 2017–2027)

  • Hospital
  • Clinics
  • Others

Geographic Segment Covered in the Report:

The Sepsis report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Sepsis industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Sepsis Market report provides key statistics on the market status of the Sepsis manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @

We appreciate you reading our report. Please touch with us to know more about the report and its customizable feature. Our team will guarantee the report is perfectly tailored to fulfil your requirements.

Get Explore Latest Research Report by Reports and Data: 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


amol shinde

127 Blog posts